Skip to main content

MOB-015 is now being launched in Sweden under the brand name Terclara * Terclara cutaneous solution 98mg/ml is an over-the-counter medicine with terbinafine for the treatment of mild to moderate nail fungus on fingernails and toenails. From 18 years. Terclara can be used if you have previously been diagnosed by a doctor. Consult a doctor or pharmacist if you are pregnant, breastfeeding, have diabetes, immune disease or peripheral vascular disease. If there is no improvement after 6 months for fingernails and 9-12 months for toenails, contact a doctor. Read the package insert carefully before use. Allderma AB,

100Million patients in EU and USA have nail fungus

76% of patients were fungus-free in phase 3 of MOB-015

70MUSD Partner agreements with potential milestone revenues of 70 MUSD

5 Commercial partner agreements in place

”I am incredibly proud that we now have an approved drug in 13 EU markets and have initiated its launch in Sweden. With Terclara®, we have the opportunity to make a real difference for millions of people suffering from nail fungus worldwide and at the same time create value for our shareholders.”

Anna Ljung, CEO

Interview with CEO Anna Ljung